Insulet Issues Medical Device Correction For Omnipod 5 Controller Due To Faulty Charging
Insulet Corporation (NASDAQ: PODD) announced a Medical Device Correction for the Omnipod 5 Automated Insulin Delivery System because of an issue with the Omnipod 5 Controller charging port and cable.
Insulet has received 24 reports that the Omnipod 5 Controller charging port (USB-C port) or cable (USB cable) is melting, deforming or discoloring due to heat generated by a poor connection between the cable and the port.
Related: Insulet Shares Jump After Q3 Earnings Surpass Expectations, Improved Annual Guidance.
The excess heat may cause minor burns if those areas of the Controller are touched or could lead to a fire. No serious injuries have been reported to Insulet as a result of this issue.
Omnipod 5 users are being notified by email with instructions on detecting and reducing the risk of an issue with the charging port or cable.
This does not impact the Omnipod 5 Pod, the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, or compatible Android smartphone devices with the Omnipod 5 App installed.
These actions are taken voluntarily with the knowledge of the FDA.
Price Action: PODD shares are up 2.82% at $298.27 on the last check Tuesday.
See more from Benzinga
Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
